LifeTech Scientific Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,370	1,304	1,267	1,097	925.33
Revenue Growth (YoY)	5.07%	2.88%	15.48%	18.58%	44.07%
Cost of Revenue	350.67	322.26	271.54	223.38	177.8
Gross Profit	1,019	981.44	995.64	873.93	747.53
Selling, General & Admin	609.02	504.2	414.59	347.7	291.18
Research & Development	242.66	302.92	297.92	208.48	145.89
Other Operating Expenses	-30.4	-37.1	-46.04	-51.24	-47.03
Operating Expenses	820.57	771.73	667.14	504.86	381.77
Operating Income	198.55	209.71	328.5	369.07	365.77
Interest Expense	-0.21	-1.89	-0.72	-0.63	-2.61
Interest & Investment Income	25.46	18.57	12.78	16.65	62.14
Earnings From Equity Investments	6.2	-0.66	-1.96	-1.77	-0.87
Currency Exchange Gain (Loss)	-4.07	2.66	13.38	53.6	-40.61
Other Non Operating Income (Expenses)	-	-1.33	1.51	-1.99	0.24
EBT Excluding Unusual Items	225.93	227.05	353.49	434.93	384.06
Gain (Loss) on Sale of Investments	6.3	38.45	35.87	-27.73	-51.08
Gain (Loss) on Sale of Assets	-3.67	-0.53	-0.06	-0.34	0.06
Asset Writedown	-18.65	-65.97	-	-21.31	-
Other Unusual Items	-18.45	-	-213.72	-7.5	-0.11
Pretax Income	191.45	199	175.58	378.05	332.93
Income Tax Expense	79.08	30.5	68.09	59.31	49.57
Earnings From Continuing Operations	112.38	168.49	107.49	318.74	283.36
Minority Interest in Earnings	35.45	53.9	155.75	6.6	9.12
Net Income	147.83	222.39	263.24	325.34	292.47
Net Income to Common	147.83	222.39	263.24	325.34	292.47
Net Income Growth	-33.53%	-15.52%	-19.09%	11.24%	35.35%
Shares Outstanding (Basic)	4,370	4,379	4,356	4,233	4,309
Shares Outstanding (Diluted)	4,418	4,394	4,446	4,405	4,563
Shares Change (YoY)	0.54%	-1.16%	0.92%	-3.45%	3.95%
EPS (Basic)	0.03	0.05	0.06	0.08	0.07
EPS (Diluted)	0.03	0.05	0.06	0.07	0.06
EPS Growth	-35.02%	-13.93%	-20.27%	15.63%	30.61%
Free Cash Flow	-	124.83	217.22	161.95	165.27
Free Cash Flow Per Share	-	0.03	0.05	0.04	0.04
Gross Margin	74.40%	75.28%	78.57%	79.64%	80.78%
Operating Margin	14.49%	16.09%	25.92%	33.63%	39.53%
Profit Margin	10.79%	17.06%	20.77%	29.65%	31.61%
Free Cash Flow Margin	-	9.57%	17.14%	14.76%	17.86%
EBITDA	277.4	288.56	391.99	421.88	414.36
EBITDA Margin	20.25%	22.13%	30.93%	38.45%	44.78%
D&A For EBITDA	78.85	78.85	63.5	52.81	48.59
EBIT	198.55	209.71	328.5	369.07	365.77
EBIT Margin	14.49%	16.09%	25.92%	33.63%	39.53%
Effective Tax Rate	41.30%	15.33%	38.78%	15.69%	14.89%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.